A 12-week, double-blind, randomised, placebo-controlled, multicentre trial to evaluate efficacy and tolerability of Antistax® film-coated tablets, 360 mg/day orally, in male and female patients suffering from chronic venous insufficiency
- Registry ID
- EUCTR2005-003771-20
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Boehringer Ingelheim GmbH
- Start date
- 2006-02-09
- Completion date
- 2006-10-12
- Last update
- 2026-08-16
Conditions
- chronic venous insufficiency
- chronic venous incufficiency
Summary
The objective of this study is to assess the efficacy and tolerability of Antistax® film-coated tablets in patients with chronic venous insufficiency (CVI, CEAP Classification: Clinical Class 3 and 4a)
Locations
- , , Germany
- , , Austria
- , , Czechia
View on source registry